OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World

Myelo 2026: Virtual Global Congress on Multiple Myeloma

Alberto Costa on a 45-Year Journey and Future Direction - European School of Oncology

Bishal Gyawali: Essential Primer on Navigating Clinical Trial Reports

10 Must-Read Posts in Immuno-Oncology This Week

Grand Rounds by OncoDaily: AI in Oncology Edition

Runcie C.W. Chidebe on GLOBOCAN 2022: Cancer Incidence and Mortality in Africa

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

IMDC Risk Score Calculator (Metastatic RCC)

Classify metastatic Renal Cell Carcinoma (RCC) prognosis using IMDC (International Metastatic RCC Database Consortium) criteria.

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

IMDC Risk Factors:

  • Time from diagnosis to treatment <1 year
  • Karnofsky Performance Status <80
  • Hemoglobin below LLN
  • Corrected calcium above ULN
  • Neutrophils above ULN
  • Platelets above ULN

Risk Categories:

  • Favorable: 0 risk factors
  • Intermediate: 1-2 risk factors
  • Poor: ≥3 risk factors

LLN = Lower Limit of Normal, ULN = Upper Limit of Normal